SCHEMBL31095221

SCHEMBL31095221

Fc1ccc(/C=C\c2cccnc2F)c(Br)c1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ NFE2L2 Q16236 6/20 0.42
▸ CYP11B2 P19099 2/20 0.39
▸ TRIM24 O15164 1/20 0.36
▸ TRIM33 Q9UPN9 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.35
▸ NAPRT Q6XQN6 1/20 0.35
▸ NPC1 O15118 1/20 0.33
▸ MTOR P42345 1/20 0.33
▸ METAP2 P50579 1/20 0.33
▸ METAP1 P53582 1/20 0.33
▸ CBFB Q13951 1/20 0.33
▸ PDE10A Q9Y233 1/20 0.33
▸ CGAS Q8N884 1/20 0.33
▸ DHODH Q02127 1/20 0.33
▸ IDO1 P14902 1/20 0.33
▸ TDO2 P48775 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31095177 0.87 NFE2L2 (0.42) NFE2L2CYP11B2TRIM24TRIM33NAPRT
SCHEMBL31095207 0.83 HSD11B1 (0.43) NFE2L2TRIM24TRIM33KDM4ENAPRT
SCHEMBL31095224 0.83 HSD11B1 (0.43) NFE2L2TRIM24TRIM33KDM4ENAPRT
SCHEMBL8486928 0.80 NAPRT (0.48) NFE2L2TRIM24TRIM33KDM4ENAPRT
SCHEMBL8486922 0.80 NAPRT (0.48) NFE2L2TRIM24TRIM33KDM4ENAPRT
SCHEMBL31095230 0.73 NFE2L2 (0.47) NFE2L2TRIM24TRIM33KDM4ENAPRT
SCHEMBL31095227 0.72 CSNK1A1 (0.38) CYP11B2TRIM24TRIM33NAPRTMETAP2
SCHEMBL31095185 0.70 NFE2L2 (0.53) NFE2L2TRIM24TRIM33KDM4ENAPRT
SCHEMBL249018 0.69 KDM4E (0.42) NFE2L2TRIM24TRIM33KDM4E
SCHEMBL29921177 0.69 KDM4E (0.42) NFE2L2TRIM24TRIM33KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4680602-A1 HETEROCYCLIC COMPOUNDS AS SELECTIVE HDAC6 INHIBITORS Miralinc Pharma, Inc. (US) 2026-01-21 — — EP disclosed
WO-2024192237-A1 HETEROCYCLIC COMPOUNDS AS SELECTIVE HDAC6 INHIBITORS MIRALINC PHARMA, INC. (US) 2024-09-19 — — WO disclosed
Send feedback